Data Management Core for a global infectious disease research program
Official title: Data Management Core
Funded at University of Florida · NIH-11507437 · Data updated 2026-11-12
A data management and biostatistics core supports a large international research program by organizing data securely and enabling high-quality analyses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | April 22, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $1,189 |
| NIH project number | 3U19AI181594-03S1 |
| Project ID | NIH-11507437 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to patient participation; the core supports data handling for studies that may involve human participants.
✕Less likely to help
Direct patient benefit is not the primary focus of this core.
What this research studies
This grant funds a central Data Management & Statistical Epidemiology core that handles data flow, storage, and secure exchange across multiple research projects and partners. It provides administrative support for analyses, builds an integrated data system, and develops standard operating procedures to protect participant confidentiality. The core helps translate complex data into usable results to advance understanding of the health issues studied by the Émergents ICEMR. Researchers and trainees at US universities may benefit from hands-on experience in data management and biostatistics. The focus is on data infrastructure that underpins multiple projects rather than on a single clinical trial.
Why it matters
Potential benefit: Improved data systems and statistical support could accelerate discoveries and strengthen research capacity.
How similar studies have gone: Similar ICEMR data management cores have enabled secure data sharing and standardized analyses across international research teams.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Dinglasan, Rhoel David Ramos — University of Florida
- Study coordinator: Dinglasan, Rhoel David Ramos
Related research
Other NIH-funded projects on the same topics.
-
Mitochondrial pores and muscle loss in cancer cachexia
A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.
-
Photobiomodulation for jaw pain from TMD
A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.
-
How the brain controls swallowing and airway protection
A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.
-
Donor-driven 3D organoid platform to study pancreatic cancer drug response
A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.
-
RAAS inhibitors and pancreatic cancer risk in diverse adults
A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.
-
Pilot project exploring new cancer drugs for pancreatic cancer in African American patients
A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.